ALFA Finder| Revenue growth | 6.7% YoY in Q4; -15.6% YoY for full FY26. |
|---|---|
| Margins | Q4 EBITDA margin 4.9% vs -8.1% YoY. FY26 margin 0.11%. |
| Demand visibility | Healthy traction in API existing molecules; Hospital segment focus. |
| Management confidence | High optimism for improving business momentum and operational efficiencies. |
Growth
Q4 revenue grew 6.7% YoY; FY26 revenue ₹342.2cr vs ₹405.5cr in FY25. EBITDA margin improved to 4.9% in Q4.
Outlook
Targeting RoW markets (CIS, GCC) in 0-3 years and regulated markets (EU, USA) in 3-5 years.
Risks
Softness in Formulations segment; high market fragmentation; long lead times for hospital reputation building.
Earnings Call filed with BSE, NSE: THEMISMED. Summary written with AI assistance from the document.
Themis Medicare Ltd: key numbers
- Share price
- ₹100.90
- Market cap
- ₹929.3 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 23.2×Sector 43.7×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Other Announcement
Themis Medicare has filed a revised September 2026 quarter shareholding pattern. It reclassifies trustees as promoter group and adds OSS Software Solutions as a nil-holding promoter group member.
Themis Medicare Board Meeting Date
Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.
Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare Annual General Meeting
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).